Radical technological breakthroughs in drugs and drug markets: The cases of cannabis and fentanyl
Cannabis legalization and the arrival of nonmedical fentanyl are fundamentally altering North American drug markets. An essential part of that change is the ability to produce large quantities of these drugs at low costs, which is like a technological breakthrough in their production technology. Thi...
Gespeichert in:
| Veröffentlicht in: | The International journal of drug policy 2021-08, Vol.94, p.103162-103162, Article 103162 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 103162 |
|---|---|
| container_issue | |
| container_start_page | 103162 |
| container_title | The International journal of drug policy |
| container_volume | 94 |
| creator | Caulkins, Jonathan P. |
| description | Cannabis legalization and the arrival of nonmedical fentanyl are fundamentally altering North American drug markets. An essential part of that change is the ability to produce large quantities of these drugs at low costs, which is like a technological breakthrough in their production technology. This essay explores possible future consequences of these trends.
Descriptive statistics, historical analogy and economic reasoning.
In North America, wholesale prices for cannabis and opioids – in the form of illegally manufactured fentanyl and other new synthetic opioids – are radically lower than they were a decade ago. Retail prices for cannabis have fallen commensurately, but not yet for opioids. Historical analogies suggest that very large declines in price can have effects on use that go beyond just an expansion of traditional patterns of consumption.
For cannabis and opioids in North America, conditions are ripe for significant changes in not only quantities consumed, and associated harms, but also in the roles these drugs and their control play in society. The overall situation with these drugs may look more different in 2040 compared to today, than today looks different from 2000. There are no obvious reasons why these trends will not spread to other continents. |
| doi_str_mv | 10.1016/j.drugpo.2021.103162 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2489596186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0955395921000608</els_id><sourcerecordid>2572614059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-68557cc8a1c142fd2c58a0e3bdda2bf5b6e64c5c0a2683f438db5e0dbad46fcb3</originalsourceid><addsrcrecordid>eNp9kctOGzEUhi3UqgToGyA0UjfdTOp7nC4qVahQJCQkBGvLlzOJw8RO7ZlKvD1OBlh00dU5x_rOxf-P0DnBc4KJ_LaZ-zyudmlOMSX1iRFJj9CMqAVr-UKoD2iGl0K0bCmWx-iklA3GmBNOPqFjxoRiUpEZMvfGB2f6ZgC3jqlPq0NlM5inYZ3TuFqXJsRmv6s0JvpD1mxNfoKhfG8e1tA4U6A0qatJjMaGiesgDiY-92foY2f6Ap9f4yl6vPr1cPm7vb27vrn8eds6zuTQSiXEwjlliCOcdp46oQwGZr031HbCSpDcCYcNlYp1nClvBWBvjeeyc5adoq_T3F1Of0Yog96G4qDvTYQ0Fk25qkpIomRFv_yDbtKYY71OU7GgknAslpXiE-VyKiVDp3c51I8_a4L13gK90ZMFem-BniyobRevw0e7Bf_e9KZ5BX5MAFQ1_gbIurgA0YEPGdygfQr_3_AC8IiaQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2572614059</pqid></control><display><type>article</type><title>Radical technological breakthroughs in drugs and drug markets: The cases of cannabis and fentanyl</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>PAIS Index</source><source>Elsevier ScienceDirect Journals</source><creator>Caulkins, Jonathan P.</creator><creatorcontrib>Caulkins, Jonathan P.</creatorcontrib><description>Cannabis legalization and the arrival of nonmedical fentanyl are fundamentally altering North American drug markets. An essential part of that change is the ability to produce large quantities of these drugs at low costs, which is like a technological breakthrough in their production technology. This essay explores possible future consequences of these trends.
Descriptive statistics, historical analogy and economic reasoning.
In North America, wholesale prices for cannabis and opioids – in the form of illegally manufactured fentanyl and other new synthetic opioids – are radically lower than they were a decade ago. Retail prices for cannabis have fallen commensurately, but not yet for opioids. Historical analogies suggest that very large declines in price can have effects on use that go beyond just an expansion of traditional patterns of consumption.
For cannabis and opioids in North America, conditions are ripe for significant changes in not only quantities consumed, and associated harms, but also in the roles these drugs and their control play in society. The overall situation with these drugs may look more different in 2040 compared to today, than today looks different from 2000. There are no obvious reasons why these trends will not spread to other continents.</description><identifier>ISSN: 0955-3959</identifier><identifier>EISSN: 1873-4758</identifier><identifier>DOI: 10.1016/j.drugpo.2021.103162</identifier><identifier>PMID: 33583681</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Analogical reasoning ; Analogies ; Cannabis ; Consumption patterns ; Decriminalization ; Drug markets ; Drug policy ; Drugs ; Fentanyl ; Futures ; Legalization ; Marijuana ; Markets ; Narcotics ; Opioids ; Prices ; Producer prices ; Radicalism ; Statistics ; Technology ; Trends</subject><ispartof>The International journal of drug policy, 2021-08, Vol.94, p.103162-103162, Article 103162</ispartof><rights>2021 The Author(s)</rights><rights>Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Aug 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-68557cc8a1c142fd2c58a0e3bdda2bf5b6e64c5c0a2683f438db5e0dbad46fcb3</citedby><cites>FETCH-LOGICAL-c436t-68557cc8a1c142fd2c58a0e3bdda2bf5b6e64c5c0a2683f438db5e0dbad46fcb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0955395921000608$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27843,27901,27902,30976,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33583681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Caulkins, Jonathan P.</creatorcontrib><title>Radical technological breakthroughs in drugs and drug markets: The cases of cannabis and fentanyl</title><title>The International journal of drug policy</title><addtitle>Int J Drug Policy</addtitle><description>Cannabis legalization and the arrival of nonmedical fentanyl are fundamentally altering North American drug markets. An essential part of that change is the ability to produce large quantities of these drugs at low costs, which is like a technological breakthrough in their production technology. This essay explores possible future consequences of these trends.
Descriptive statistics, historical analogy and economic reasoning.
In North America, wholesale prices for cannabis and opioids – in the form of illegally manufactured fentanyl and other new synthetic opioids – are radically lower than they were a decade ago. Retail prices for cannabis have fallen commensurately, but not yet for opioids. Historical analogies suggest that very large declines in price can have effects on use that go beyond just an expansion of traditional patterns of consumption.
For cannabis and opioids in North America, conditions are ripe for significant changes in not only quantities consumed, and associated harms, but also in the roles these drugs and their control play in society. The overall situation with these drugs may look more different in 2040 compared to today, than today looks different from 2000. There are no obvious reasons why these trends will not spread to other continents.</description><subject>Analogical reasoning</subject><subject>Analogies</subject><subject>Cannabis</subject><subject>Consumption patterns</subject><subject>Decriminalization</subject><subject>Drug markets</subject><subject>Drug policy</subject><subject>Drugs</subject><subject>Fentanyl</subject><subject>Futures</subject><subject>Legalization</subject><subject>Marijuana</subject><subject>Markets</subject><subject>Narcotics</subject><subject>Opioids</subject><subject>Prices</subject><subject>Producer prices</subject><subject>Radicalism</subject><subject>Statistics</subject><subject>Technology</subject><subject>Trends</subject><issn>0955-3959</issn><issn>1873-4758</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>7TQ</sourceid><recordid>eNp9kctOGzEUhi3UqgToGyA0UjfdTOp7nC4qVahQJCQkBGvLlzOJw8RO7ZlKvD1OBlh00dU5x_rOxf-P0DnBc4KJ_LaZ-zyudmlOMSX1iRFJj9CMqAVr-UKoD2iGl0K0bCmWx-iklA3GmBNOPqFjxoRiUpEZMvfGB2f6ZgC3jqlPq0NlM5inYZ3TuFqXJsRmv6s0JvpD1mxNfoKhfG8e1tA4U6A0qatJjMaGiesgDiY-92foY2f6Ap9f4yl6vPr1cPm7vb27vrn8eds6zuTQSiXEwjlliCOcdp46oQwGZr031HbCSpDcCYcNlYp1nClvBWBvjeeyc5adoq_T3F1Of0Yog96G4qDvTYQ0Fk25qkpIomRFv_yDbtKYY71OU7GgknAslpXiE-VyKiVDp3c51I8_a4L13gK90ZMFem-BniyobRevw0e7Bf_e9KZ5BX5MAFQ1_gbIurgA0YEPGdygfQr_3_AC8IiaQw</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Caulkins, Jonathan P.</creator><general>Elsevier B.V</general><general>Elsevier Science Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7TQ</scope><scope>8BJ</scope><scope>DHY</scope><scope>DON</scope><scope>FQK</scope><scope>JBE</scope><scope>7X8</scope></search><sort><creationdate>20210801</creationdate><title>Radical technological breakthroughs in drugs and drug markets: The cases of cannabis and fentanyl</title><author>Caulkins, Jonathan P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-68557cc8a1c142fd2c58a0e3bdda2bf5b6e64c5c0a2683f438db5e0dbad46fcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analogical reasoning</topic><topic>Analogies</topic><topic>Cannabis</topic><topic>Consumption patterns</topic><topic>Decriminalization</topic><topic>Drug markets</topic><topic>Drug policy</topic><topic>Drugs</topic><topic>Fentanyl</topic><topic>Futures</topic><topic>Legalization</topic><topic>Marijuana</topic><topic>Markets</topic><topic>Narcotics</topic><topic>Opioids</topic><topic>Prices</topic><topic>Producer prices</topic><topic>Radicalism</topic><topic>Statistics</topic><topic>Technology</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caulkins, Jonathan P.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>PAIS Index</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>MEDLINE - Academic</collection><jtitle>The International journal of drug policy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caulkins, Jonathan P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radical technological breakthroughs in drugs and drug markets: The cases of cannabis and fentanyl</atitle><jtitle>The International journal of drug policy</jtitle><addtitle>Int J Drug Policy</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>94</volume><spage>103162</spage><epage>103162</epage><pages>103162-103162</pages><artnum>103162</artnum><issn>0955-3959</issn><eissn>1873-4758</eissn><abstract>Cannabis legalization and the arrival of nonmedical fentanyl are fundamentally altering North American drug markets. An essential part of that change is the ability to produce large quantities of these drugs at low costs, which is like a technological breakthrough in their production technology. This essay explores possible future consequences of these trends.
Descriptive statistics, historical analogy and economic reasoning.
In North America, wholesale prices for cannabis and opioids – in the form of illegally manufactured fentanyl and other new synthetic opioids – are radically lower than they were a decade ago. Retail prices for cannabis have fallen commensurately, but not yet for opioids. Historical analogies suggest that very large declines in price can have effects on use that go beyond just an expansion of traditional patterns of consumption.
For cannabis and opioids in North America, conditions are ripe for significant changes in not only quantities consumed, and associated harms, but also in the roles these drugs and their control play in society. The overall situation with these drugs may look more different in 2040 compared to today, than today looks different from 2000. There are no obvious reasons why these trends will not spread to other continents.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33583681</pmid><doi>10.1016/j.drugpo.2021.103162</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0955-3959 |
| ispartof | The International journal of drug policy, 2021-08, Vol.94, p.103162-103162, Article 103162 |
| issn | 0955-3959 1873-4758 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2489596186 |
| source | Applied Social Sciences Index & Abstracts (ASSIA); PAIS Index; Elsevier ScienceDirect Journals |
| subjects | Analogical reasoning Analogies Cannabis Consumption patterns Decriminalization Drug markets Drug policy Drugs Fentanyl Futures Legalization Marijuana Markets Narcotics Opioids Prices Producer prices Radicalism Statistics Technology Trends |
| title | Radical technological breakthroughs in drugs and drug markets: The cases of cannabis and fentanyl |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T07%3A48%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radical%20technological%20breakthroughs%20in%20drugs%20and%20drug%20markets:%20The%20cases%20of%20cannabis%20and%20fentanyl&rft.jtitle=The%20International%20journal%20of%20drug%20policy&rft.au=Caulkins,%20Jonathan%20P.&rft.date=2021-08-01&rft.volume=94&rft.spage=103162&rft.epage=103162&rft.pages=103162-103162&rft.artnum=103162&rft.issn=0955-3959&rft.eissn=1873-4758&rft_id=info:doi/10.1016/j.drugpo.2021.103162&rft_dat=%3Cproquest_cross%3E2572614059%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2572614059&rft_id=info:pmid/33583681&rft_els_id=S0955395921000608&rfr_iscdi=true |